The sea urchin complement homologue, SpC3, functions as an opsonin von Clow, Lori A, Raftos, David A, Gross, Paul S, Smith, L Courtney

Volltext

Echinoderm immunity and the evolution of the complement system von Gross, Paul S, Al-Sharif, Walid Z, Clow, Lori A, Smith, L.Courtney

Volltext

The ancestral complement system in sea urchins von Smith, L. Courtney, Clow, Lori A., Terwilliger, David P.

Volltext

SpC3, the complement homologue from the purple sea urchin, Strongylocentrotus purpuratus, is expressed in two subpopulations of the phagocytic coelomocytes von Gross, P S, Clow, L A, Smith, L C

Volltext

Constitutive expression and alternative splicing of the exons encoding SCRs in Sp152, the sea urchin homologue of complement factor B. Implications on the evolution of the Bf/C2 ge... von Terwilliger, David P, Clow, Lori A, Gross, Paul S, Smith, L Courtney

Volltext

Cold Acclimation-Associated Changes in Brown Adipose Tissue do Not Necessarily Indicate an Increase of Nonshivering Thermogenesis in C57BL/6J Mice von TALAN, MARK I, KIROV, SERGEY A, CLOW, LORI A, KOSHELEVA, NADEJDA A

Volltext

Expression of SpC3, the sea urchin complement component, in response to lipopolysaccharide von Clow, L A, Gross, P S, Shih, C S, Smith, L C

Volltext

The ancestral complement system in sea urchins: Immunobiology of complement von SMITH, L. Courtney, CLOW, Lori A, TERWILLIGER, David P

Volltext

Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma von Wang, Michael L, Rule, Simon, Martin, Peter, Goy, Andre, Auer, Rebecca, Kahl, Brad S, Jurczak, Wojciech, Advani, Ranjana H, Romaguera, Jorge E, Williams, Michael E, Barrientos, Jacqueline C, Chmielowska, Ewa, Radford, John, Stilgenbauer, Stephan, Dreyling, Martin, Jedrzejczak, Wieslaw Wiktor, Johnson, Peter, Spurgeon, Stephen E, Li, Lei, Zhang, Liang, Newberry, Kate, Ou, Zhishuo, Cheng, Nancy, Fang, Bingliang, McGreivy, Jesse, Clow, Fong, Buggy, Joseph J, Chang, Betty Y, Beaupre, Darrin M, Kunkel, Lori A, Blum, Kristie A

Volltext

Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials von Brown, Jennifer R, Moslehi, Javid, O'Brien, Susan, Ghia, Paolo, Hillmen, Peter, Cymbalista, Florence, Shanafelt, Tait D, Fraser, Graeme, Rule, Simon, Kipps, Thomas J, Coutre, Steven, Dilhuydy, Marie-Sarah, Cramer, Paula, Tedeschi, Alessandra, Jaeger, Ulrich, Dreyling, Martin, Byrd, John C, Howes, Angela, Todd, Michael, Vermeulen, Jessica, James, Danelle F, Clow, Fong, Styles, Lori, Valentino, Rudy, Wildgust, Mark, Mahler, Michelle, Burger, Jan A

Volltext

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phas... von Moreno, Carol, Greil, Richard, Demirkan, Fatih, Tedeschi, Alessandra, Anz, Bertrand, Larratt, Loree, Simkovic, Martin, Samoilova, Olga, Novak, Jan, Ben-Yehuda, Dina, Strugov, Vladimir, Gill, Devinder, Gribben, John G, Hsu, Emily, Lih, Chih-Jian, Zhou, Cathy, Clow, Fong, James, Danelle F, Styles, Lori, Flinn, Ian W

Volltext

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia von Burger, Jan A, Tedeschi, Alessandra, Barr, Paul M, Robak, Tadeusz, Owen, Carolyn, Ghia, Paolo, Bairey, Osnat, Hillmen, Peter, Bartlett, Nancy L, Li, Jianyong, Simpson, David, Grosicki, Sebastian, Devereux, Stephen, McCarthy, Helen, Coutre, Steven, Quach, Hang, Gaidano, Gianluca, Maslyak, Zvenyslava, Stevens, Don A, Janssens, Ann, Offner, Fritz, Mayer, Jiří, O’Dwyer, Michael, Hellmann, Andrzej, Schuh, Anna, Siddiqi, Tanya, Polliack, Aaron, Tam, Constantine S, Suri, Deepali, Cheng, Mei, Clow, Fong, Styles, Lori, James, Danelle F, Kipps, Thomas J

Volltext

A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbio... von Okhuysen, Pablo C, Ramesh, Mayur S, Louie, Thomas, Kiknadze, Nino, Torre-Cisneros, Julian, de Oliveira, Claudia Murta, Van Steenkiste, Christophe, Stychneuskaya, Alena, Garey, Kevin W, Garcia-Diaz, Julia, Li, Jianling, Duperchy, Esther, Chang, Betty Y, Sukbuntherng, Juthamas, Montoya, Jose G, Styles, Lori, Clow, Fong, James, Danelle, Dubberke, Erik R, Wilcox, Mark

Volltext

Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT von Ryan, Christine E., Sahaf, Bita, Logan, Aaron C., O'Brien, Susan, Byrd, John C., Hillmen, Peter, Brown, Jennifer R., Dyer, Martin J.S., Mato, Anthony R., Keating, Michael J., Jaglowski, Samantha, Clow, Fong, Rezvani, Andrew R., Styles, Lori, Coutre, Steven E., Miklos, David B.

Volltext

Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study von Waller, Edmund K., Miklos, David, Cutler, Corey, Arora, Mukta, Jagasia, Madan H., Pusic, Iskra, Flowers, Mary E.D., Logan, Aaron C., Nakamura, Ryotaro, Chang, Stephen, Clow, Fong, Lal, Indu D., Styles, Lori, Jaglowski, Samantha

Volltext

Median 3.5-Year Follow-up of Ibrutinib Treatment in Patients with Relapsed/Refractory Mantle Cell Lymphoma: A Pooled Analysis von Rule, Simon, Dreyling, Martin, Goy, Andre, Hess, Georg, Auer, Rebecca, Kahl, Brad S, Hernandez-Rivas, Jose Angel, Londhe, Anil, Clow, Fong, Deshpande, Sanjay, Parisi, Lori, Wang, Michael

Volltext

Ibrutinib + Obinutuzumab Versus Chlorambucil + Obinutuzumab As First-Line Treatment in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL): Results f... von Moreno, Carol, Greil, Richard, Demirkan, Fatih, Tedeschi, Alessandra, Anz, Bertrand, Larratt, Loree, Simkovic, Martin, Samoilova, Olga, Novak, Jan, Ben-Yehuda, Dina, Strugov, Vladimir, Gill, Devinder, Gribben, John G., Hsu, Emily, Zhou, Cathy, Clow, Fong, James, Danelle F., Styles, Lori, Flinn, Ian W.

Volltext

Open label evaluation of ECG in patients with chronic lymphocytic leukemia (CLL) receiving ibrutinib monotherapy von Loury, David, Sukbuntherng, Juthamas, Clow, Fong, James, Danelle Frances, Kunkel, Lori A.

Volltext

730. A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Ridinilazole Compared with Vancomycin for the Treatment of Clostridioides difficile Infection von Okhuysen, Pablo C, Ramesh, Mayur, Garey, Kevin W, Louie, Thomas J, Cisneros, Julian Torre, Stychneuskaya, Alena, Kiknadze, Nino, LI, Jianling, Duperchy, Esther, Wilcox, Professor Mark H, Montoya, Jose G, Styles, Lori, Clow, Fong, James, Danelle, Dubberke, Erik R, De Oliveira, Claudia M, Van Steenkiste, Christophe

Volltext

Modeling absolute lymphocyte counts after treatment of chronic lymphocytic leukemia with ibrutinib von Smith, David D., Goldstein, Leanne, Cheng, Mei, James, Danelle F., Kunkel, Lori A., Fardis, Maria, Hamdy, Ahmed, Izumi, Raquel, Buggy, Joseph J., Clow, Fong

Volltext